"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Cell therapy, specifically replenishing dopamine ... explored the safety of a dopaminergic neuron progenitor cell product (bemdaneprocel) derived from human embryonic stem cells.

This finding will enable the furthering of advances in cell therapy for treating various neurodegenerative diseases, such as Huntington's disease and epilepsy. "An adult neuron cannot be divided.

Studies found that cell therapy could replenish dopamine-producing ... Center in the US explored the safety of a dopaminergic neuron progenitor cell product (bemdaneprocel) derived from human ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing. The oversubscribed financing round was backed by more than 15 ...

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.